Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP646516.RA9lx4fymBLuGLAjn_9ElR5dzk9VT2N2iFyQnoBZsFhe0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP646516.RA9lx4fymBLuGLAjn_9ElR5dzk9VT2N2iFyQnoBZsFhe0130_assertion type Assertion NP646516.RA9lx4fymBLuGLAjn_9ElR5dzk9VT2N2iFyQnoBZsFhe0130_head.
- NP646516.RA9lx4fymBLuGLAjn_9ElR5dzk9VT2N2iFyQnoBZsFhe0130_assertion description "[The study results are significant in the development of novel anti-tumoral therapeutic strategies directed to c-MYC-overexpressing tumors and establish AVI-4126 as a strong clinical candidate for metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646516.RA9lx4fymBLuGLAjn_9ElR5dzk9VT2N2iFyQnoBZsFhe0130_provenance.
- NP646516.RA9lx4fymBLuGLAjn_9ElR5dzk9VT2N2iFyQnoBZsFhe0130_assertion evidence source_evidence_literature NP646516.RA9lx4fymBLuGLAjn_9ElR5dzk9VT2N2iFyQnoBZsFhe0130_provenance.
- NP646516.RA9lx4fymBLuGLAjn_9ElR5dzk9VT2N2iFyQnoBZsFhe0130_assertion SIO_000772 18096271 NP646516.RA9lx4fymBLuGLAjn_9ElR5dzk9VT2N2iFyQnoBZsFhe0130_provenance.
- NP646516.RA9lx4fymBLuGLAjn_9ElR5dzk9VT2N2iFyQnoBZsFhe0130_assertion wasDerivedFrom befree-2016 NP646516.RA9lx4fymBLuGLAjn_9ElR5dzk9VT2N2iFyQnoBZsFhe0130_provenance.
- NP646516.RA9lx4fymBLuGLAjn_9ElR5dzk9VT2N2iFyQnoBZsFhe0130_assertion wasGeneratedBy ECO_0000203 NP646516.RA9lx4fymBLuGLAjn_9ElR5dzk9VT2N2iFyQnoBZsFhe0130_provenance.